mRNA vaccines : present scenario, challenges and future.

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

Falguni Pradip Sapkal

mRNA vaccines : present scenario, challenges and future.

Authors: Falguni Pradip Sapkal

Unique Paper ID: 169880
Volume: 11
Issue: 6
PageNo: 2476-2481

Keywords: mRNA vaccines lipid nanoparticles virus cancer .

Abstract:
The mRNA vaccines supplement our conventional vaccines (live-attenuated and inactivated vaccines) in reality by their extremely safety, efficacy, potency, and low manufacturing cost. These many years, the administration of these mRNA vaccines was immensely limited due to their instability and low efficiency in vivo delivery. However, at present, some of the problems have been solved through recent technological advances. The positive outcomes of mRNA vaccines were proved by the conducted studies with animals and humans to show the success. This study presents you with a thorough introduction of mRNA viral vaccines and assesses the current points of view and future advancements.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 6
PageNo: 2476-2481

mRNA vaccines : present scenario, challenges and future.

Available:https://ijirt.org/article?manuscript=169880

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now